anti-LGR5 polyclonal antibody (mAbRx)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-LGR5 polyclonal antibody (mAbRx)
Drug Alias Nameanti-GPR49 polyclonal antibody (mAbRx)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Polyclonal antibodies
Mechanisms of ActionLeucine-rich repeat-containing G-protein coupled receptor 5 modulators
TargetsLeucine-rich repeat-containing G-protein coupled receptor 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesmAbRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesmAbRx Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A